Achieve Life Sciences: The Recent Sell Off Skews The Outcomes [Seeking Alpha]
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: Seeking Alpha
Cytisinicline demonstrates strong efficacy and a superior safety profile versus Chantix, supporting blockbuster potential in smoking cessation. Manufacturing issues prompted a supplier switch to Adare Pharma; FDA approval probability is estimated at 35% on the first try, rising to 70% if resubmitted. DCF analysis suggests a $10 target price upon approval, with a positive expected value despite dilution and commercial risks. J Studios/DigitalVision via Getty Images Achieve Life Sciences (NASDAQ: ACHV ) is a clinical stage biopharmaceutical firm devoted to treating nicotine dependency. Their main product, dubbed cytisinicline, is a plant-derived alkaloid with the ability to bind the same receptors as nicotine. The drug is
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable TolerabilityGlobeNewswire
- Achieve Life Sciences (ACHV) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.MarketBeat
- Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Achieve Life Sciences GAAP EPS of -$0.28 misses by $0.01 [Seeking Alpha]Seeking Alpha
ACHV
Earnings
- 3/24/26 - Miss
ACHV
Analyst Actions
- 3/25/26 - HC Wainwright
ACHV
Sec Filings
- 3/24/26 - Form S-8
- 3/24/26 - Form 10-K
- 3/24/26 - Form 8-K
- ACHV's page on the SEC website